Report Content
Chapter 1 Methodology
1.1 Industry coverage
1.2 Market scope & definitions
1.3 Base estimates & working
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at country level
1.6 Data validation
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Business trends
Chapter 3 US Clinical Nutrition Industry Insights
3.1 Industry landscape, 2018 - 2032 (USD Million)
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing metabolic disorders and other chronic diseases
3.2.1.2 High junk food consumption leading to malnourishment
3.2.1.3 Rising geriatric population
3.2.1.4 Increasing incidence of pre-mature birth & birth rate
3.2.1.5 Increasing adoption of home healthcare
3.2.2 Industry pitfalls & challenges
3.2.2.1 Stringent government regulations
3.3 Growth potential analysis
3.3.1 By product
3.3.2 By consumer
3.3.3 By application
3.3.4 By distribution channel
3.3.5 By dosage formulation
3.4 COVID-19 impact analysis
3.5 Key market trends
3.6 Technology landscape
3.7 Supply chain analysis for clinical nutrition
3.8 Dietary supplements usage scenario in U.S.
3.9 Regulatory landscape
3.10 Porter’s analysis
3.11 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Strategy dashboard, 2022
Chapter 5 US Clinical Nutrition Market, By Product
5.1 Key product trends
5.2 Infant nutrition
5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.2 Milk based
5.2.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.3 Soy based
5.2.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.4 Organic formulas
5.2.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.5 Others
5.2.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3 Enteral nutrition
5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.2 Standard composition
5.3.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.3 Disease specific composition
5.3.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4 Parenteral nutrition
5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4.2 Amino acids
5.4.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4.3 Fats
5.4.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4.4 Carbohydrates
5.4.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4.5 Others
5.4.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 6 US Clinical Nutrition Market, By Consumer
6.1 Key consumer trends
6.2 Pediatric
6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3 Adult
6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 7 US Clinical Nutrition Market, By Application
7.1 Key application trends
7.2 Cancer
7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.3 Metabolic disorders
7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.4 Neurological diseases
7.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.5 Gastrointestinal disorders
7.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.6 Others
7.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 8 US Clinical Nutrition Market, By Distribution Channel
8.1 Key distribution channel trends
8.2 Retail stores
8.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.3 Pharmacies & drug stores
8.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.4 Online channels
8.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.5 Others
8.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 9 US Clinical Nutrition Market, By Dosage Formulation
9.1 Key dosage formulation trends
9.2 Powder
9.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
9.3 Liquid
9.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
9.4 Solid
9.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 10 Company Profiles
10.1 Abbott Laboratories (Abbott Nutrition)
10.2 B Braun Melsungen AG
10.3 Baxter International Inc.
10.4 Fresenius Kabi
10.5 Mead Johnson (Reckitt Benckiser)
10.6 Nestle Health Science
10.7 Perrigo
10.8 Pfizer, Inc.
10.9 Danone
10.10 Hero Nutritionals Inc.
10.11 Aculife Healthcare Pvt Ltd
10.12 Hormel Foods Corporation
10.13 BASF SE
10.14 Meiji Holdings Co Ltd.
10.15 Grifols SA
